Neurology · Brain Fog · Cognitive Recovery
You used to be sharp. You used to hold a conversation without losing the thread, read a book without re-reading the same paragraph three times, drive to a familiar destination without suddenly wondering if you've passed your turn. You used to be you.
Then Lyme happened. And somewhere in the months or years that followed, the person who lived in your mind — alert, clear, present — started to fade. You developed what the Lyme community calls "brain fog," and what the medical community has struggled to explain, treat, or even fully acknowledge.
This article is about what's actually happening in your brain — and what can be done about it that goes beyond what's available in North America.
One of the most frustrating experiences for chronic Lyme patients is hearing the phrase "brain fog" used dismissively — as though it were a complaint about feeling a little tired, rather than a description of a life being fundamentally altered.
The cognitive symptoms of chronic Lyme disease are real, measurable, and well-documented in the peer-reviewed literature:
SPECT imaging studies of chronic Lyme patients have shown hypoperfusion — reduced blood flow — in the frontal and temporal lobes. PET scans have revealed patterns of neuroinflammation consistent with other inflammatory brain conditions. This is not "just stress." This is physiology.
There are multiple overlapping mechanisms that drive Lyme-associated cognitive symptoms, and understanding them matters because different mechanisms respond to different interventions.
Borrelia and co-infections trigger the activation of microglia — the brain's resident immune cells. When activated chronically, microglia release inflammatory cytokines that disrupt neuronal signaling, impair synaptic plasticity, and reduce blood flow to prefrontal areas responsible for executive function. This is the same mechanism implicated in long COVID cognitive symptoms, which is why researchers in both fields are now sharing data.
Systemic inflammation doesn't stay in the body. Inflammatory cytokines cross the blood-brain barrier and directly alter neurotransmitter metabolism — reducing serotonin and dopamine availability, dysregulating the HPA axis, and impairing the hippocampal neurogenesis that underlies memory consolidation.
Borrelia has documented endothelial tropism — it adheres to and inflames blood vessel walls. In cerebral vasculature, this means reduced microvascular perfusion and impaired delivery of oxygen and glucose to neurons. The brain is extraordinarily sensitive to even small reductions in blood supply.
The immune system in chronic Lyme is not just fighting infection. It has lost regulatory control — it is firing constantly, nonspecifically, and in ways that cause collateral damage throughout the body, including the brain. Restoring this regulation is not something antibiotics can accomplish.
Most North American physicians addressing Lyme-associated cognitive symptoms reach for one of two tools: more antibiotics, or symptom management (antidepressants, stimulants, sleep medications). Neither addresses the underlying mechanisms.
Antibiotics target bacteria. They do not reduce neuroinflammation, restore immune regulation, clear inflammatory cytokines from the bloodstream, or repair vascular damage. A patient who has taken two years of doxycycline and still has brain fog is not a patient who needs a third year of doxycycline. They are a patient whose immune system needs direct intervention.
At the Lyme Immunotherapy Center, our approach to Lyme-associated cognitive symptoms addresses the mechanisms driving them:
We use specialized blood filtration to remove circulating inflammatory cytokines, immune complexes, and neurotoxic compounds from the bloodstream. Patients frequently report that their thinking becomes noticeably clearer within days of apheresis — not because we treated the brain directly, but because we removed the systemic inflammatory signals that were disrupting it. Think of it as cleaning the water the brain has to swim in.
Our autologous Treg therapy uses the patient's own regulatory T cells — expanded in the laboratory and reinfused — to restore the immune system's ability to self-regulate. When the immune system stops firing nonspecifically, neuroinflammation decreases. This is not a short-term suppression. It is a fundamental reset of immune governance.
Raising core body temperature to 41.5–42°C under medical supervision targets heat-sensitive bacteria while simultaneously producing a potent immune-modulatory effect. Heat shock proteins activated during hyperthermia have documented anti-inflammatory properties in the central nervous system. Many patients report cognitive improvement in the weeks following hyperthermia that they attribute to nothing else in their protocol.
We want to be honest: cognitive recovery from Lyme-associated neuroinflammation is not always linear. Some patients experience rapid, dramatic improvement. Others experience gradual clearing over weeks and months as inflammation decreases and neurological repair occurs. The brain has remarkable plasticity, but it needs the right internal environment to use it.
What we can tell you is that patients who have spent years managing brain fog with supplements and symptom medications — and who then address the underlying immune dysregulation directly — frequently describe a qualitative shift in their cognition that they had stopped believing was possible.
The version of yourself that was sharp and present is not gone. The fog obscuring them is addressable. And we have the tools to address it.
Our protocols specifically address the immune and inflammatory mechanisms driving brain fog. Tell us about your case and we'll evaluate whether our programs are right for you.
Check My Eligibility